First line asciminib in chronic myeloid leukemia: a quest for the “Holy Grail” of tolerability.
Year: 2026
Type: article
Abstract: Not available.
Source: Haematologica
Author: Delphine Rea
Institution: Hôpital Saint-Louis
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,157
OpenAlex ID: W7212163989
FWCI:
Cites:
Cited by:
Related to: